PubMed Health⌕ Search

PubMed · 15032650

Endothelial dysfunction and coronary artery spasm.

Abstract

Coronary spasm plays an important role in the pathogenesis of not only variant angina but also coronary heart disease in general including acute coronary syndromes. The incidence of coronary spasm in Japanese patients with angina pectoris was about 40%. The total number of patients with angina pectoris increases with old age. The patients' age distribution was relatively younger in the coronary spasm than in the stable effort angina. The vascular endothelium has been reported to be a multifunctional organ whose integrity is essential to normal vascular physiology, and whose dysfunction can be a critical factor in the pathogenesis of vascular disease. Acetylcholine and methacholine cause vasodilation by endothelium-derived relaxing factor when endothelium is functioning normal, whereas they cause vasoconstriction when endothelium is removed or damaged. Coronary spasm can be induced by acetylcholine and methacholine. The patients with coronary spasm may have a disturbance in the endothelial function of the coronary arteries.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hiroaki Kawano, Hisao Ogawa. 2004. Endothelial dysfunction and coronary artery spasm.. https://doi.org/10.2174/1568006043481301

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris.

OBJECTIVE: Ischemic preconditioning is an increased tolerance to myocardial ischemia during the second of two consecutive exercise tests. ATP-sensitive K(+) channel blockers, such as glinides and sulfonylurea drugs, can induce loss of ischemic preconditioning. This study aimed to investigate the effects of repaglinide, a hypoglycemic agent with an affinity for myocardial ATP-sensitive K (+)channels, on the results of consecutive exercise tests in patients with diabetes and multivessel coronary artery disease. METHODS: Forty-two patients with type 2 diabetes and chronic stable angina pectoris, and two-vessel or three-vessel disease participated in this study. The patients underwent two consecutive treadmill exercise tests (phase 1). On the day after these exercise tests, 2 mg of oral repaglinide was given to the patients. One week later, two exercise tests were repeated consecutively (phase 2). RESULTS: All patients achieved 1.0-mm ST-segment depression during the four exercise tests (T1, T2, T3, and T4). In phase 2, seven patients improved in time to onset of 1.0-mm ST-segment depression. The worsening of the time to onset of 1.0-mm ST-segment depression in phase 2 demonstrated ischemic preconditioning block in 83.3% of patients (P=0.0001). Even the postexercise electrocardiographic parameters (ST-segment depression morphology and magnitude and arrhythmias) were significantly different between the groups with and without pharmacologic ischemic preconditioning block (P=0.031). CONCLUSIONS: Repaglinide, an oral hypoglycemic agent with ATP-sensitive K(+) channel-blocker activity, eliminated the myocardial ischemic preconditioning in patients with coronary disease and diabetes.

Angina Pectoris↗